SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001516551-23-000107
Filing Date
2023-12-22
Accepted
2023-12-21 19:07:11
Documents
6
Effectiveness Date
2023-12-22

Document Format Files

Seq Description Document Type Size
1 S-8 skye-12212023_sx8.htm S-8 88623
2 EX-FILING FEES ex107filingfeetable.htm EX-FILING FEES 19054
3 EX-5.1 ex51opinionoffennemorecrai.htm EX-5.1 11889
4 EX-23.2 ex232consentofmarcumllp.htm EX-23.2 2564
5 EX-23.3 ex233consentofmhmpc.htm EX-23.3 3211
6 GRAPHIC fennemorea.jpg GRAPHIC 1871
  Complete submission text file 0001516551-23-000107.txt   129403
Mailing Address 11250 EL CAMINO REAL, SUITE 100 SAN DIEGO CA 92130
Business Address 11250 EL CAMINO REAL, SUITE 100 SAN DIEGO CA 92130 (858) 410-0266
Skye Bioscience, Inc. (Filer) CIK: 0001516551 (see all company filings)

IRS No.: 450692882 | State of Incorp.: NV | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-276211 | Film No.: 231506813
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)